managing-bariatric-surgery-pathways

name	managing-bariatric-surgery-pathways
language	en
description	Structures bariatric surgery evaluation with insurance requirements, preoperative optimization, and post-surgical nutrition protocols. Use when evaluating bariatric candidates, documenting insurance criteria, or managing post-bariatric care.
tags	["management","surgery","surgical","valuation"]
metadata	{"author":"casemark","practice_areas":["General Surgery","Surgical Subspecialties"],"document_types":["Management Report"],"skill_modes":["Management","Coordination"]}

Managing Bariatric Surgery Pathways

Structures bariatric surgery evaluation with insurance requirements, preoperative optimization, and post-surgical nutrition protocols.

Why This Skill Exists

Bariatric surgery is the most effective long-term treatment for morbid obesity and its metabolic comorbidities. The ASMBS/IFSO 2022 updated guidelines expanded eligibility to BMI ≥35 regardless of comorbidities, or BMI 30-34.9 with metabolic disease. Despite this, bariatric surgery is the most heavily gatekept surgical procedure in the US healthcare system — insurance companies require extensive preoperative documentation including 3-7 months of supervised weight management, psychological evaluation, nutritional counseling, and documentation of comorbidity severity. Incomplete documentation is the primary reason for insurance denials.

MBSAQIP (Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program) accreditation requires standardized patient evaluation, multidisciplinary team involvement, and long-term follow-up data collection. Bariatric programs that fail to track outcomes lose accreditation and face significant reputational and financial consequences. This skill structures the complete bariatric pathway from initial evaluation through long-term postoperative management, ensuring both clinical excellence and insurance/accreditation compliance.

---

Checkpoint A: Pre-Draft Intake (Mandatory)

1. What is the patient's current BMI and highest documented BMI? Default: [VERIFY]
2. What obesity-related comorbidities are documented (T2DM, HTN, OSA, NASH, GERD, OA, etc.)? Default: [VERIFY]
3. What prior weight loss attempts have been made (diet, exercise, medications, programs)? Default: [VERIFY]
4. What insurance plan does the patient have, and what are its specific bariatric surgery requirements? Default: [VERIFY — contact insurance for policy]
5. Has the patient completed or started a supervised weight management program? Default: not yet started
6. Has psychological evaluation been completed? Default: no
7. Does the patient have a history of substance abuse? Default: no
8. What procedure is being considered (sleeve gastrectomy, Roux-en-Y gastric bypass, SADI-S, revision)? Default: to be determined after evaluation

Documents to Request

• Insurance policy bariatric surgery requirements (letter of medical necessity template)
• Prior weight loss program documentation (physician-supervised diet records)
• Psychological evaluation report
• Nutrition consultation records
• Sleep study results (if OSA suspected or documented)
• Endocrine evaluation (TSH, cortisol if clinically indicated)
• Upper GI endoscopy or UGI series (per ASMBS guidelines)
• MBSAQIP data collection forms
• Current medication list (especially diabetes, HTN, psych medications)

---

Step 1: Patient Eligibility Assessment

NIH/ASMBS Criteria for Bariatric Surgery

Criterion	Requirement	Documentation
BMI ≥40	Morbid obesity without comorbidities required	Height and weight with date (minimum 2 documented BMI measurements)
BMI 35-39.9	With at least one obesity-related comorbidity	Documented comorbidity with treatment records
BMI 30-34.9	With metabolic disease (T2DM, per 2022 ASMBS/IFSO update)	Documented T2DM with A1c, medication history
Failed conservative therapy	Prior attempts at weight loss documented	6+ months of documented diet/exercise/behavioral modification
Age	Generally 18-65 (some programs evaluate 65+)	Birth date
Psychological readiness	Evaluated by mental health professional	Formal psychological evaluation report

Comorbidity Documentation

Document each comorbidity with objective evidence:

Comorbidity	Required Documentation	Measurement
Type 2 Diabetes	A1c, fasting glucose, medication list, duration	A1c ≥6.5% or on antidiabetic medication
Hypertension	BP readings, medication list	BP >130/80 on ≥2 occasions or on antihypertensive
OSA	Polysomnography (sleep study) with AHI	AHI ≥5 (mild), ≥15 (moderate), ≥30 (severe)
NASH/NAFLD	Liver function tests, imaging, possible biopsy	Elevated ALT, steatosis on imaging
GERD	Symptom documentation, PPI use, possible pH study	Endoscopy may be required for procedure selection
Osteoarthritis	Imaging, functional limitation documentation	Weight-bearing joint involvement
Depression	PHQ-9, treatment records	Active treatment, medication list

---

Step 2: Insurance Authorization Process

Common Insurance Requirements (vary by plan)

Requirement	Typical Standard	Documentation Needed
Letter of medical necessity	Written by bariatric surgeon	Template with BMI, comorbidities, failed treatments, surgical plan
Supervised weight management	3-7 consecutive months of physician visits	Monthly visit notes with weight, diet counseling, exercise plan
Nutritional evaluation	1-2 sessions with registered dietitian	RD assessment with dietary history and education plan
Psychological evaluation	Completed by licensed psychologist/psychiatrist	Standardized report addressing motivation, comprehension, substance abuse, eating disorders
Sleep study	If OSA suspected	Polysomnography report
Cardiac clearance	If significant cardiac history	Cardiology note
Documentation of comorbidities	Objective evidence for each	Lab results, imaging, specialist notes
Primary care clearance	Medical clearance letter	PCP letter confirming patient is suitable for surgery

Letter of Medical Necessity Template Components

1. Patient demographics and BMI history (highest, current, duration of obesity)
2. Complete list of obesity-related comorbidities with objective evidence
3. History of failed conservative weight loss attempts with specifics
4. Current medications required for obesity-related conditions
5. Proposed surgical procedure with rationale
6. Expected outcomes (comorbidity resolution rates specific to the proposed procedure)
7. Surgeon credentials and program MBSAQIP accreditation status
8. References to ASMBS/NIH consensus guidelines supporting surgical eligibility

---

Step 3: Preoperative Optimization

Medical Clearance Workup

Test	Purpose	When to Order
CBC, BMP, LFTs	Baseline labs, screen for liver disease	All patients
A1c	Diabetes status	All patients
TSH	Rule out hypothyroidism as weight contributor	All patients
Lipid panel	Cardiovascular risk baseline	All patients
Iron studies, B12, folate, vitamin D, thiamine	Baseline nutritional status	All patients (especially for bypass)
Cortisol or dexamethasone suppression test	Rule out Cushing's syndrome	If clinical suspicion
Polysomnography	Screen for OSA	All patients (unless recently completed)
EGD (upper endoscopy)	Screen for H. pylori, Barrett's, hiatal hernia	Recommended for all; mandatory before bypass
UGI series	Anatomy assessment	Some programs; alternative to EGD
Echocardiogram	Cardiac function	If cardiac symptoms, OSA, or pulmonary HTN suspected

Preoperative Targets

• A1c <8% (ideally <7%) for elective surgery
• CPAP compliance documented if OSA (≥4h/night, ≥70% of nights for 30 days)
• Smoking cessation ≥6 weeks (cotinine testing may be required)
• Alcohol cessation documented
• Weight loss of 5-10% of excess body weight (liver shrinkage diet for 2-4 weeks preop) — reduces liver volume and improves surgical access

---

Step 4: Procedure Selection

Comparison of Common Bariatric Procedures

Factor	Sleeve Gastrectomy (SG)	Roux-en-Y Gastric Bypass (RYGB)	SADI-S/DS
Mechanism	Restriction	Restriction + malabsorption	Restriction + significant malabsorption
Expected %EWL at 5 yr	55-65%	65-75%	70-80%
T2DM remission rate	60-70%	80-85%	85-95%
Operative time	60-90 min	90-150 min	120-180 min
Nutritional deficiency risk	Low-moderate	Moderate	High
GERD impact	May worsen	Resolves (preferred if GERD present)	Variable
Surgical complexity	Low	Moderate	High
Revision rate	5-15% (inadequate weight loss, GERD)	5-10%	<5%

Key procedure selection factors:

• GERD or Barrett's esophagus → RYGB preferred (SG may worsen)
• BMI >50 → Consider RYGB or SADI-S for greater expected weight loss
• Medication absorption concerns → SG preferred (no bypass of absorption sites)
• Prior abdominal surgery with hostile abdomen → SG preferred (simpler operation)
• T2DM as primary indication → RYGB or SADI-S (higher metabolic resolution rates)

---

Step 5: Postoperative Nutrition and Long-Term Follow-Up

Postoperative Diet Progression

Phase	Timeframe	Allowed	Volume
Phase 1 — Clear liquids	POD 0-1	Water, broth, sugar-free gelatin	1 oz Q15 min
Phase 2 — Full liquids	Weeks 1-2	Protein shakes, strained soups, yogurt drinks	2-4 oz Q30 min
Phase 3 — Pureed	Weeks 3-4	Pureed protein sources, soft scrambled eggs	4-6 oz per meal
Phase 4 — Soft foods	Weeks 5-8	Ground meats, soft fish, cooked vegetables	4-6 oz per meal
Phase 5 — Regular	Week 8+	All foods tolerated; avoid carbonation, high sugar	4-8 oz per meal

Lifetime Supplementation (procedure-dependent)

Supplement	SG	RYGB	SADI-S/DS
Multivitamin with iron	1 daily	2 daily	2 daily
Calcium citrate + Vitamin D	1200 mg + 3000 IU daily	1500 mg + 3000 IU daily	1800 mg + 5000 IU daily
Vitamin B12	500 mcg sublingual daily or 1000 mcg IM monthly	Same	Same
Iron (menstruating women)	45-65 mg elemental daily	Same	Same
Fat-soluble vitamins (A, D, E, K)	Standard MVI	Standard MVI	Additional supplementation required
Thiamine	As needed	As needed	Routine

MBSAQIP Follow-Up Schedule

Timeframe	Visit	Labs
2 weeks	Wound check, diet progression	—
6 weeks	Weight, diet, activity assessment	—
3 months	Weight, comorbidity assessment, diet compliance	CBC, BMP, nutritional labs
6 months	Weight, comorbidity resolution documentation	Nutritional labs, A1c
12 months	Weight nadir assessment, comorbidity status	Complete nutritional panel, A1c, lipids
Annually (lifelong)	Weight, nutrition, comorbidity status	Annual nutritional labs

---

Checkpoint B: Post-Draft Alignment (Mandatory)

1. Does the patient meet NIH/ASMBS eligibility criteria with documented BMI and comorbidities?
2. Is the insurance authorization complete with all required elements (supervised weight management, psych eval, nutritional eval)?
3. Is the procedure selection documented with rationale addressing patient-specific factors (GERD, BMI, T2DM)?
4. Is the preoperative optimization complete (A1c target, CPAP compliance, liver shrinkage diet)?
5. Is the postoperative nutrition and follow-up plan documented per MBSAQIP requirements?

---

Quality Audit

• BMI documented with height and weight (minimum 2 measurements with dates)
• Comorbidities documented with objective evidence (labs, studies, specialist notes)
• Prior weight loss attempts documented with specifics (program, duration, outcome)
• Supervised weight management visits documented (monthly, consecutive)
• Psychological evaluation completed by licensed professional
• Nutritional evaluation completed by registered dietitian
• Insurance authorization obtained with all required documentation
• Preoperative labs and studies completed (including EGD and sleep study)
• A1c within target range for elective surgery
• CPAP compliance documented (if OSA)
• Smoking and alcohol cessation documented
• Liver shrinkage diet prescribed and initiated 2-4 weeks preop
• Procedure selection documented with patient-specific rationale
• Postoperative diet progression plan provided to patient
• Lifetime supplementation regimen prescribed
• MBSAQIP follow-up schedule documented

---

Guidelines

1. Never proceed to surgery without complete insurance authorization — retrospective denial after a bariatric procedure creates catastrophic revenue loss and patient financial burden.
2. The supervised weight management period must be consecutive and documented monthly. A gap of >30 days between visits may reset the clock per most insurance policies.
3. EGD is strongly recommended by ASMBS for all bariatric patients and is mandatory before Roux-en-Y gastric bypass. H. pylori must be treated before surgery. Barrett's esophagus is a relative contraindication to sleeve gastrectomy.
4. Psychological evaluation must address substance abuse history, binge eating disorder, psychiatric stability, and informed understanding of the lifelong dietary and lifestyle changes required. Active untreated substance abuse or bulimia are contraindications.
5. Lifetime nutritional supplementation is non-negotiable, especially after bypass procedures. Thiamine deficiency can cause irreversible Wernicke encephalopathy, and calcium/vitamin D deficiency leads to metabolic bone disease.
6. MBSAQIP requires long-term follow-up data. Programs that lose patients to follow-up jeopardize accreditation. Document follow-up compliance rates and implement outreach for patients overdue for visits.
7. For patients with BMI 30-34.9, the 2022 ASMBS/IFSO update supports surgery for metabolic disease — but insurance coverage for this population remains inconsistent. Document the guideline citation in the letter of medical necessity.